encyclopedia of medical concepts
ψ
ψ
ψ
Aclarubicin
More information
in Books
or on
Definition
: An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.
Pharmacological Action
Antibiotics, Antineoplastic
Other names
Aclacinomycin A; NSC208734; NSC 208734; MA144A1; NSC-
208734; Medac Brand of Aclarubicin Hydrochloride; MA 144A1; MA-
144A1; Lundbeck Brand of Aclarubicin Hydrochloride; Aclaplastin; Aclacin
Substance
CAS Registry & name
Categories
Source
Drugs
*
10-
decarboxymethylaclacinomycin T
0
Aclarubicin/*analogs & derivatives.
J Biol Chem 2003 Oct 3;278(40):39006-13
15-
demethoxyaclacinomycin T
0
Aclarubicin/*analogs & derivatives.
J Biol Chem 2003 Oct 3;278(40):39006-13
BHAC-
AMP protocol
0
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine/analogs & derivatives
Prednisolone
6-Mercaptopurine
Aclarubicin.
Int J Hematol 2001 Jul;74(1):53-7
CAG protocol
0
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Aclarubicin
Granulocyte Colony-Stimulating Factor.
Int J Hematol 2000 Apr;71(3):238-44
CAOP protocol
0
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Prednisolone
Vincristine
Aclarubicin.
Cancer Genet Cytogenet 1996 Aug;90(1):45-8
11-
hydroxyaclacinomycin X
0
Aclarubicin/*analogs & derivatives.
J Antibiot (Tokyo) 1996 Apr;49(4):355-60
11-
hydroxyaclacinomycin A
0
Aclarubicin/*analogs & derivatives.
Antimicrob Agents Chemother 1995 Jul;39(7):1616-20
2-
hydroxyaclacinomycin B
85819-82-5
Aclarubicin/*analogs & derivatives.
Jpn J Antibiot 1991;44(3):277
BGM 84 protocol
0
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Aclarubicin.
Nouv Rev Fr Hematol 1990;32(2):147
ABEP protocol 1
0
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine/analogs & derivatives
Etoposide
Prednisolone
Aclarubicin.
Cancer Chemother Pharmacol 1989;25(2):135
AB-
triple V protocol
0
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine/analogs & derivatives
Etoposide
Vinblastine
Vincristine
Aclarubicin.
Rinsho Ketsueki 1989;30(2):169
AclBEP protocol
0
*Antineoplastic Combined Chemotherapy Protocols
Etoposide
Prednisolone
Aclarubicin.
Nippon Gan Chiryo Gakkai Shi 1987;22(6):1176
CAP therapy protocol
0
*Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Aclarubicin
Peplomycin.
Nippon Sanka Fujinka Gakkai Zasshi 1986;38(11):2119
BH-
AC-
AMP protocol
0
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine/analogs & derivatives
Prednisolone
6-Mercaptopurine
Aclarubicin.
Rinsho Ketsueki 1984;25(11):1766
6-
O-
methylaclacinomycin
76264-92-1
Aclarubicin/*analogs & derivatives.
J Antibiot (Tokyo):1981;34(7):905
4-
O-
methylaclacinomycin
76304-86-4 1-
Naphthacenecarboxylic acid, 2-
ethyl-
1,2,3,4,6,11-
hexahydro-
2,5-
dihydroxy-
7-
methoxy-
6,11-
dioxo-
4-
((2,3,6-
trideoxy-
4-
O-
(2,6-
dideoxy-
4-
O-
((2R-
trans)-
tetrahydro-
6-
methyl-
5-
oxo-
2H-
pyran-
2-
yl)-
alpha-
L-
lyxo-
hexopyranosyl)-
3-
(dimethylamino)-
alpha-
L-
lyxo-
hexopy
Aclarubicin/*analogs & derivatives.
J Antibiot (ToKyo) 1981;34(7):905
aclacinomycins
0
Aclarubicin/*analogs & derivatives.
Pharma Action
Adjuvants, Immunologic
;
Antibiotics, Antineoplastic
Antibiot Chemother 23:76;1978; Biochem Biophys Res Commun 82(1):188;1978; Biochemistry 1979;18(18):4024; Cancer Res 38:1782;1978; Cancer Treat Rep 63(5):875;1979; Cancer Treat Rep 63(5):931;1979; Folia Microbiol 23:152;1978; Gann 68(5):685;1977; J Antibiot (Tokyo) 32(1):48;1979; J Antibiot 1979;32(5):472; J Antibiotics 28(10):830;1975; J Antibiotics 31(9):919;1978; Jpn J Antibiot 30 suppl:S-70;1977; Lancet 2(8137):301;1979; Recent Results Canc Res 63:241;1978
2-
hydroxyaclacinomycin A
79127-36-9 1-
Naphthacenecarboxylic acid, 2-
ethyl-
1,2,3,4,6,11-
hexahydro-
2,5,7,9-
tetrahydroxy-
6,11-
dioxo-
4-
((2,3,6-
trideoxy-
4-
O-
(2,6-
dideoxy-
4-
O-
((2R-
trans)-
tetrahydro-
6-
methyl-
5-
oxo-
2H-
pyran-
2-
yl)-
alpha-
L-
lyxo-
hexopyranosyl)-
3-
(dimethylamino)-
alpha-
L-
lyxo-
hexopyran
Aclarubicin/*analogs & derivatives.
J Antibiot (Tokyo) 1981;34(11):1494